Updated Date: Wed, 29 Apr 2020 00:00:00 EDT
The approval gives NSCLC patients whose tumours carry the MET exon 14 skipping mutation a new treatment option
Amgen is planning to file for FDA approval of Otezla in mild to moderate plaque psoriasis based on […]
Guidelines that advise doctors to manage common infant symptoms as cow’s milk allergy are not evidence based and […]
A High Court judge has ruled that an elderly woman with terminal cancer should be released immediately from […]
The UK’s death toll from covid-19 has exceeded 32 000, making it the worst affected country in Europe, […]
The news on cardiopulmonary resuscitation (CPR) in covid-191 is the latest example of the state of confusion, denial, […]
German drugmaker Fresenius Kabi has made major investments in its U.S. manufacturing operations in recent years with some […]
AstraZeneca has watched superstar SGLT2 diabetes med Farxiga nail trial after trial in highly coveted kidney and heart failure […]